A NEW POSSIBILITY FOR WEIGHT MANAGEMENT ?

Experts are increasingly focused on retatrutide, a novel drug developed by Eli Lilly, as a possible advance in body reduction . Unlike many existing approaches, retatrutide is a dual -action receptor targeting simultaneously GLP-1 and GIP, substances that influence satiety and blood sugar regula